Respiratory Distress in the Preterm Infant

Avery's Diseases of the Newborn

Volumn , Issue , 2005, Pages 687-703

  Welty, Stephen ^a,b   Hansen, Thomas N ^a,b   Corbet, Anthony ^c,d  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d Children's Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845670643     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-072169347-7.50049-4     Document Type: Chapter

References (169)

1. Abman SH, Kinsella JP, Schaffer MS, et al. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress syndrome and pulmonary hypertension. Pediatrics 1993, 92:606.
2. ACTOBAT Study Group Australian Collaborative Trial of Antenatal Thyrotropin Releasing Hormone (ACTOBAT) for prevention of neonatal respiratory disease. Lancet 1995, 345:877.
3. Adams FH, Fujiwara T, Emmanouilides GC, Raiha N Lung phospholipids of human fetuses and infants with and without hyaline membrane disease. Pediatrics 1970, 77:833.
4. Adams FH, Fujiwara T, Rowshan G The nature and origin of the fluid in the fetal lamb lung. J Pediatr 1963, 63:881.
5. Adamson TM, Boyd RDH, Platt HS, et al. Composition of alveolar liquid in the foetal lamb. J Physiol 1969, 204:159.
6. Avery ME, Fletcher BD The Lung and Its Disorders in the New born Infant 1974, WB Saunders, Philadelphia.
7. Avery ME, Gatewood OB, Brumley G Transient tachypnea of newborn: Possible delayed resorption of fluid at birth. Am J Dis Child 1966, 111:380.
8. Avery ME, Mead J Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959, 97:517.
9. Ballard PL Hormones and Lung Maturation 1986, Springer-Verlag, New York.
10. Ballard RA, Ballard PL, Creasy R, et al. Respiratory disease in very low birth weight infants after prenatal thyrotropin releasing hormone and glucocorticoid. Lancet 1992, 339:510.
11. Ballard RA, Ballard PL, Cnann A, et al. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group. N Engl J Med 1998, 338:493.
12. Banks BA, Cnann A, Morgan MA, et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 1999, 181:709.
13. Bell EF, Acarregui MJ Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001, 3.
14. Benatar SR, Hewlett AM, Nunn JF The use of iso-shunt lines for control of oxygen therapy. Br J Anaesthesiol 1973, 45:711.
15. Berthiaume Y, Staub NC, Matthay MA Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest 1987, 79:335.
16. Bland RD, Albertine KH, Carlton DP, et al. Chronic lung injury in preterm lambs: Abnormalities of the pulmonary circulation and lung fluid balance. Pediatr Res 2000, 48:64.
17. Bland RD, Nielson DW Developmental changes in lung epithelial ion transport and liquid movement. Annu Rev Physiol 1992, 54:373.
18. Bland RD, Bressack MA, McMillan DD Labor decreases the lung water content of newborn rabbits. Am J Obstet Gynecol 1979, 35:364.
19. Bland RD Dynamics of pulmonary water before and after birth. Acta Paediatr Scand 1983, 305(suppl):12.
20. Bland RD Lung liquid clearance before and after birth. Semin Perinatol 1988, 12:124.
21. Bland RD, Hansen TN, Haberkern CM, et al. Lung fluid balance in lambs before and after birth. J Appl Physiol 1982, 53:992.
22. Boughton K, Gandy G, Gairdner D Hyaline membrane disease II. Lung lecithin. Arch Dis Child 1970, 45:311.
23. Brumley GW, Hodson WA, Avery ME Lung phospholipids and surface tension correlations in infants with and without hyaline membrane disease. Pediatrics 1967, 40:13.
24. Brus F, van Oeveren WV, Okken A, et al. Number and activation of circulating polymorphonuclear leukocyte and platelets are associated with neonatal respiratory distress syndrome severity. Pediatrics 1997, 99:672.
25. Buss IH, Senthilmohan R, Darlow BA, et al. 3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: Association with adverse respiratory outcome. Pediatr Res 2003, 53:455.
26. Chida S, Fujiwara T Stable microbubble test for predicting the risk of respiratory distress syndrome: comparisons with other predictors of fetal lung maturity in amniotic fluid. Eur J Pediatr 1993, 152:148.
27. Chida S, Fujiwara T, Konishi M, et al. Stable microbubble test for predicting the risk of respiratory distress syndrome: Prospective evaluation of the test on amniotic fluid and gastric aspirate. Eur J Pediatr 1993, 152:152.
28. Christopher Roze J, Tohier C, Maingueneau C, et al. Response to dobutamine and dopamine in the hypotensive very preterm infant. Arch Dis Child 1993, 69:59.
29. Chu J, Clements JA, Cotton EK, et al. Neonatal pulmonary ischemia: Clinical and physiological studies. Pediatrics 1967, 40:709.
30. Clements JA, Platzker ACG, Tierney DF, et al. Assessment of the risk of respiratory distress syndrome by a rapid test for surfactant in amniotic fluid. N Engl J Med 1972, 286:1077.
31. Clements JA, Tooley WH Kinetics of surface active material in the fetal lung. Development of the Lung 1977, Marcel Dekker, New York. W.A. Hodson (Ed.).
32. Clyman RI, Ballard PL, Sniderman S, et al. Prenatal administration of betamethasone for prevention of patent ductus arteriosus. J Pediatr 1981, 98:123.
33. Committee on the Fetus and Newborn Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002, 109:330.
34. Corbet A Medical manipulation of the ductus arteriosus. The Science and Practice of Pediatric Cardiology 1996, Lea & Febiger, Philadelphia. A. Garson, J.T. Bricker, D.J. Fisher, S.R. Neish (Eds.).
35. Corbet AJS, Adams JM, Kenny JD, et al. Controlled trial of bicarbonate therapy in high risk premature newborn infants. J Pediatr 1977, 91:771.
36. 2 in hyaline membrane disease. J Appl Physiol 1974, 36:74.
37. Costarino AT, Gruskay JA, Corcoran L, et al. Sodium restriction versus daily maintenance replacement in very low birth weight premature neonates: A randomized blind therapeutic trial. J Pediatr 1992, 120:99.
38. Crowley P, Chalmers I, Keirse MJNC The effects of corticosteroid administration before preterm delivery: An overview of the evidence from controlled trials. Br J Obstet Gynecol 1990, 97:11.
39. Crowley P Corticosteroids after preterm premature rupture of membranes. Obstet Gynecol Clin North Am 1992, 19:317.
40. Cummings JJ, Carlton DP, Poulain FR, et al. Hypoproteinemia slows lung liquid clearance in young lambs. J Appl Physiol 1993, 74:153.
41. Dalence CR, Bowie LJ, Dohnal JC, et al. Amniotic fluid lamellar body count: A rapid and reliable fetal lung maturity test. Obstet Gynecol 1995, 86:235.
42. de Mello DE, Chi EY, Doo E, Lagunoff D Absence of tubular myelin in lungs of infants dying with hyaline membrane disease. Am J Pathol 1987, 127:131.
43. Dilger I, Schwedler G, Dudenhausen JW Determination of the pulmonary surfactant associated protein SP-B in amniotic fluid with a competition ELISA. Gynecol Obstet Invest 1994, 38:24.
44. Dreizzen E, Migdal M, Praud JP, et al. Passive compliance of total respiratory system in preterm newborn infants with respiratory distress syndrome. J Pediatr 1988, 112:778.
45. Dudell GG, Gersony WM Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr 1984, 104:915.
46. Edberg KE, Sandberg K, Silberberg A, et al. Lung volume, gas mixing, and mechanics of breathing in mechanically ventilated very low birth weight infants with idiopathic respiratory distress syndrome. Pediatr Res 1991, 30:496.
47. Evans N, Iyer P Change in blood pressure after treatment of patent ductus arteriosus with indomethacin. Arch Dis Child 1993, 68:584.
48. Farrell PM, Avery ME State of the art: Hyaline membrane disease. Am Rev Respir Dis 1975, 111:657.
49. Farrell PM, Wood RE Epidemiology of hyaline membrane disease in the United States: Analysis of national mortality statistics. Pediatrics 1976, 58:167.
50. Fauser A, Pohlandt F, Bartmann P, Gortner L Rapid increase of blood pressure in extremely low birth weight infants after a single dose of dexamethasone. Eur J Pediatr 1993, 152:354.
51. Fedrick J, Butler NR Hyaline membrane disease. Lancet 1972, 2:768.
52. Finlay-Jones JM, Papadimitriou JM, Barter RA Pulmonary hyaline membrane: Light and election microscopic study of the early stage. J Pathol 1974, 112:117.
53. Frank L, Lewis PL, Sosenko IRS Dexamethasone-stimulated fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics 1985, 75:569.
54. French NP, Hagan R, Evans SF, et al. Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol 1999, 180:114.
55. Gandy G, Jacobson W, Gairdner D Hyaline membrane disease: Cellular changes. Arch Dis Child 1970, 45:289.
56. Garite TJ, Rumney PJ, Briggs GG, et al. A randomized placebo controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24-28 weeks gestation. Am J Obstet Gynecol 1992, 166:646.
57. Gaylord MS, Lorch S, Lorch V, Wright P The novel use of sterile water gastric drips for management of fluid and electrolyte abnormalities in extremely low birth weight infants. Neonat Intensive Care 1995, May:44.
58. Gill AB, Weindling AM Echocardiographic assessment of cardiac function in shocked very low birth weight infants. Arch Dis Child 1993, 68:17.
59. Gill AB, Weindling AM Randomised controlled trial of plasma protein fraction versus dopamine in hypotensive very low birth weight infants. Arch Dis Child 1993, 69:284.
60. Glass L, Rajegowda BK, Evans HE Absence of respiratory distress syndrome in premature infants of heroin addicted mothers. Lancet 1971, 2:685.
61. Gluck L, Kulovich MV The evaluation of functional maturity in the human fetus. Modern Perinatal Medicine 1974, Year Book Medical Publishers, Chicago. L. Gluck (Ed.).
62. Gluck L, Kulovich MV Lecithin-sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy. Am J Obstet Gynecol 1973, 115:539.
63. Golan A, Zalzstein E, Zmora E, et al. Pulmonary hypertension in respiratory distress syndrome. Pediatr Pulmonol 1995, 19:221.
64. Gribetz I, Frank NR, Avery ME Static volume pressure relations of excised lungs of infants with hyaline membrane disease, newborn and stillborn infants. J Clin Invest 1959, 38:2168.
65. Hack M, Fanaroff A, Klaus M Neonatal respiratory distress following elective delivery: A preventable disease?. Am J Obstet Gynecol 1976, 126:43.
66. Hallak MB, Bottoms SF Accelerated pulmonary maturation from preterm premature rupture of membranes: A myth. Am J Obstet Gynecol 1993, 169:1045.
67. Halliday HL, McClure G, McCreid M Transient tachypnoea of the newborn: Two distinct clinical entities?. Arch Dis Child 1981, 56:322.
68. Hallman M, Kulovich MV, Kirkpatrick E, et al. Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: Indices of lung maturity. Am J Obstet Gynecol 1976, 125:613.
69. Hallman M, Teramo K Measurement of the lecithin-sphingomyelin ratio and phosphatidylglycerol in amniotic fluid: An accurate method for the assessment of fetal lung maturity. Br J Obstet Gynaecol 1981, 88:806.
70. 2 in hyaline membrane disease. Pediatr Res 1979, 13:1167.
71. Harker LC, Merritt TA, Edwards DK Improving the prediction of surfactant deficiency in very low birth weight infants with respiratory distress. J Perinatol 1992, 12:129.
72. Helbock HJ, Insoft RM, Conte FA Glucocorticoid responsive hypotension in extremely low birth weight newborns. Pediatrics 1993, 92:715.
73. Hibbard JU, Hibbard MC, Whalen MP Umbilical cord blood gases and mortality and morbidity in the very low birth weight infant. Obstet Gynecol 1991, 78:768.
74. Hjalmarson O, Olsson T Mechanical and ventilatory parameters in healthy and diseased newborn infants. Acta Paediatr Scand (Suppl) 1974, 247:26.
75. Hulsey TC, Alexander GR, Robillard PY, et al. Hyaline membrane disease: The role of ethnicity and maternal risk factors. Am J Obstet Gynecol 1993, 168:572.
76. Humphreys PW, Normand ICS, Reynolds EOR, et al. Pulmonary lymph flow and the uptake of liquid from the lungs of the lamb at the start of breathing. J Physiol 1967, 193:1.
77. Ikegami M, Jobe AH, Berry D A protein that inhibits surfactant in respiratory distress syndrome. Biol. Neonate 1986, 50:121.
78. Ikegami M, Jobe AH, Tabor BL, et al. Lung albumin recovery in surfactant treated preterm ventilated lambs. Am Rev Respir Dis 1992, 145:1005.
79. Ikegami M, Ueda T, Absolom D, et al. Changes in exogenous surfactant in ventilated preterm lamb lungs. Am Rev Respir Dis 1993, 148:837.
80. Jackson JC, Palmer S, Truog WE, et al. Surfactant quantity and composition during recovery from hyaline membrane disesase. Pediatr Res 1986, 20:1243.
81. James LS Perinatal events and respiratory distress syndrome. N Engl J Med 1975, 292:1291.
82. Jefferies AL, Coates G, O'Brodovich H Pulmonary epithelial permeability in hyaline membrane disease. N Engl J Med 1984, 311:1075.
83. Jobe AH Pulmonary surfactant therapy. N Engl J Med 1993, 328:861.
84. Jobe AH, Wada N, Berry LM, et al. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol 1998, 178:880.
85. Joint Working Party of the Royal College of Physicians Development of audit measures and guidelines for good practice in the management of neonatal respiratory distress syndrome. Arch Dis Child 1992, 67:1221.
86. Jones MD, Burd LI, Bowes WA, et al. Failure of association of premature rupture of membranes with respiratory distress syndrome. N Engl J Med 1975, 292:1253.
87. Jost A, Policard A Contribution expérimentale a l'étude du développement du poumon chez le lapin. Arch Anat Microsc 1948, 37:323.
88. Kattner E, Metze B, Waib E, Obladen M Accelerated lung maturation following maternal steroid treatment in infants born before 30 weeks gestation. J Perinatal Med 1992, 20:449.
89. Kenny JD, Adams JM, Corbet AJS, Rudolph AJ The role of acidosis at birth in the development of hyaline membrane disease. Pediatrics 1976, 58:184.
90. Kenny JD, Corbet AJS, Adams JM, Rudolph AJ Hyaline membrane disease and acidosis at birth in twins. Obstet Gynecol 1977, 50:710.
91. Kjos SL, Walther FJ, Montoro M, et al. Prevalence and etiology of respiratory distress syndrome in infants of diabetic mothers: Predictive values of fetal lung maturation tests. Am J Obstet Gynecol 1990, 163:898.
92. Klarr JM, Faix RG, Pryce CJE, et al. Randomized blind trial of dopamine versus dobutamine in preterm infants with respiratory distress syndrome. J Pediatr 1994, 125:117.
93. Knight DB, Liggins GC, Wealthall SR A randomized controlled trial of antepartum thyrotropin releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. Am J Obstet Gynecol 1994, 171:11.
94. Kopelman AE Blood pressure and cerebral ischemia in very low birth weight infants. J Pediatr 1990, 116:1000.
95. Kopelman AE, Moise AA, Holbert D, et al. A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants. J Pediatr 1999, 135:345.
96. Krauss AN, Auld PAM Pulmonary gas trapping in premature infants. Pediatr Res 1971, 5:10.
97. Krauss AN, Klain DB, Auld PAM Carbon monoxide diffusing capacity in newborn infants. Pediatr Res 1976, 10:771.
98. 2 in hyaline membrane disease. Pediatr Res 1986, 20:884.
99. Lawson EE, Birdwell RL, Huang PS, Taeusch HW Augmentation of pulmonary surfactant secretion by lung expansion at birth. Pediatr Res 1979, 13:611.
100. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics 2001, 107:E1.
101. Liggins GC, Howie RN A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972, 50:515.
102. Lucey JF Clinical uses of transcutaneous oxygen monitoring. Adv Pediatr 1981, 28:27.
103. Macklem PT, Proctor DF, Hogg JC The stability of peripheral airways. Respir Physiol 1970, 8:191.
104. Ment LR, Oh W, Ehrenkranz RA, et al. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol 1995, 172:795.
105. Miller HC, Futrakul P Birth weight, gestational age and sex as determining factors in the incidence of respiratory distress syndrome of prematurely born infants. J Pediatr 1968, 72:628.
106. Moise AA, Wearden ME, Kozinetz CA, et al. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics 1995, 95:845.
107. Morrison JJ, Rennie JM, Milton PJ Neonatal respiratory morbidity and mode of delivery at term: Influence of timing of elective cesarian section. Br J Obstet Gynecol 1995, 102:101.
108. Morrow RW, Taylor AF, Kinsella JP, et al. Effect of ductal patency on organ blood flow and pulmonary function in the preterm baboon with hyaline membrane disease. Crit Care Med 1995, 23:179.
109. Moscoso P, Goldberg RN, Jamieson J, Bancalari E Spontaneous elevation in arterial blood pressure during the first hours of life in the very low birth weight infant. J Pediatr 1983, 103:114.
110. Naeye RL, Freeman RK, Blanc WA Nutrition, sex, and fetal lung maturation. Pediatr Res 1974, 8:200.
111. National Institutes of Health Consensus Development Panel Antenatal corticosteroids revisited: Repeat courses-National Institutes of Health Consensus Development Conferences Statement, August 17-18, 2000. Obstet Gynecol 2001, 98:144.
112. Nelson NM, Prod'hom LS, Cherry RB, et al. Pulmonary function in the newborn infant. Perfusion, estimation by analysis of the arterial-alveolar carbon dioxide difference. Pediatrics 1962, 30:975.
113. NIH Consensus Development Conference Statement Effect of corticosteroids for fetal maturation on perinatal outcomes, 1994. Am J Obstet Gynecol 1995, 173:246.
114. NIH Consensus Development Panel Effect of corticosteroids for fetal maturation of perinatal outcomes. JAMA 1995, 273:413.
115. Nilsson R, Grossman G, Robertson B Lung surfactant and the pathogenesis of neonatal bronchiolar lesions induced by artificial ventilation. Pediatr Res 1978, 12:249.
116. Nupponen I, Pesonen E, Andersson S, et al. Neutrophil activation in preterm infants who have respiratory distress syndrome. Pediatrics 2002, 110:36.
117. Okajima S, Matsuda T, Cho K, et al. Antenatal dexamethasone administration impairs normal postnatal lung growth in rats. Pediatr Res 2001, 49:777.
118. Olver RE, Strang LB Ion fluxes across the pulmonary epithelium and secretion of lung liquid in the foetal lamb. J Physiol 1974, 241:327.
119. Orzalesi MM, Motoyama EK, Jacobson HN, et al. The development of the lungs of lambs. Pediatrics 1965, 35:373.
120. Padbury JF, Agata Y, Baylen BG, et al. Dopamine pharmacokinetics in critically ill newborn infants. J Pediatr 1986, 110:293.
121. Pena IC, Teberg AJ, Finella KM The premature small for gestational age infant during the first year of life: Comparison by birth weight and gestational age. J Pediatr 1988, 113:1066.
122. 2 exposure. Pediatr Res 1992, 32:407.
123. Pryhuber GS, Hull WM, Fink I, et al. Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturation. Pediatr Res 1991, 30:597.
124. Reller MD, et al. Duration of ductal shunting in healthy preterm infants: An echocardiographic color flow Doppler study. J Pediatr 1988, 112:441.
125. Reller MD, Rice MJ, McDonald RW Review of studies evaluating ductal patency in the premature infant. J Pediatr 1993, 122:S59.
126. Richardson CP, Jung AL Effects of continuous positive airway pressure on pulmonary function and blood gases of infants with respiratory distress syndrome. Pediatr Res 1978, 12:771.
127. Richardson DK, Torday JS Racial differences in predictive value of the lecithin/sphingomyelin ratio. Am J Obstet Gynecol 1994, 170:1273.
128. Richardson P, Bose CL, Carlstrom JR The functional residual capacity of infants with respiratory distress syndrome. Acta Paediatr Scand 1986, 75:267.
129. Richardson P, Jarriel S, Hansen TN Mechanics of the respiratory system during passive exhalation in preterm lambs. Pediatr Res 1989, 26:425.
130. Richardson P, Pace WR, Valdes E, et al. Time dependence of lung mechanics in preterm lambs. Pediatr Res 1992, 31:276.
131. Rider E, Jobe A, Ikegami M, et al. Effects of maternal corticosteroid dose on surfactant pool sizes, protein leaks and SPC precursor incorporation in preterm rabbits. Clin Res 1989, 37:207A.
132. Rieutort M, Farrell PM, Engle MJ, et al. Changes in surfactant phospholipids in fetal rat lungs from normal and diabetic pregnancies. Pediatr Res 1986, 20:650.
133. Robert MF, Neff RK, Hubbell JP, et al. Association between maternal diabetes and the respiratory distress syndrome in the newborn. N Engl J Med 1976, 294:357.
134. Ronconi M, Fortunato A, Soffiati G, et al. Vasopressin, atrial natriuretic factor and renal water homeostatis in premature newborn infants with respiratory distress syndrome. J Perinat Med 1995, 23:307-314.
135. Ryan CA, Finer NN Antenatal corticosteroid therapy to prevent respiratory distress syndrome. J Pediatr 1995, 126:317.
136. Saigal S, Wilson R, Usher R Radiological findings in symptomatic neonatal plethora resulting from placental transfusion. Radiology 1977, 125:1851.
137. Samiec TD, Radmacher P, Hill T, Adamkin DH Measured energy expenditure in mechanically ventilated very low birth weight infants. Am J Med Sci 1994, 307:182.
138. Scholle S, Braunlich H Effects of prenatally administered thyroid hormones or glucocorticoids on maturation of kidney function in newborn rats. Dev Pharmacol Ther 1989, 112:162.
139. Scott SM, Watterberg KL Effect of gestational age, postnatal age, and illness on plasma cortisol concentrations in premature infants. Pediatr Res 1995, 37:112.
140. Seeger W, Grube C, Gunther A, Schmidt R Surfactant inhibition by plasma proteins: Differential sensitivity of various surfactant proteins. Eur Respir J 1993, 6:971.
141. Seppanen MP, Kaapa PO, Kiro PO, Saraste M Doppler derived systolic pulmonary artery pressure in acute neonatal respiratory distress syndrome. Pediatrics 1994, 93:769.
142. Sinclair JC Pathophysiology of hyaline membrane disease. The Body Fluids in Pediatrics 1973, Little, Brown, Boston. R.W. Winter (Ed.).
143. Skelton R, Jeffery H Click test: Rapid diagnosis of the respiratory distress syndrome. Pediatr Pulmonol 1994, 17:383.
144. Stefano JL, Norman ME, Morales MC, et al. Decreased erythrocyte sodium-potassium-ATPase activity associated with cellular potassium loss in extremely low birth weight infants with non-oliguric hyperkalemia. J Pediatr 1993, 122:276.
145. Stonestreet BS, Hansen MB, Laptock AR, et al. Glucocorticoids accelerate renal function maturation in fetal lambs. Early Hum Dev 1983, 8:331.
146. Strang LB Uptake of liquid from the lungs at the start of breathing. CIBAFoundation Symposium: Development of the Lung 1967, J & A Churchill, London. A.V.S. DeReuch, R. Porter (Eds.).
147. Strang LB, MacLeish MH Ventilatory failure and right to left shunt in newborn infants with respiratory distress. Pediatrics 1961, 28:17.
148. Tammela KT, Lanning FP, Koivisto ME The relationship of fluid restriction during the first month of life and the occurrence and severity of bronchopulmonary dysplasia in low birth weight infants: A 1 year radiological follow up. Eur J Pediatr 1992, 151:367.
149. Tejani N, Verma UL Correlation of Apgar scores and umbilical artery acid base status to mortality and morbidity in the low birth weight infant. Obstet Gynecol 1989, 73:597.
150. Thompson PJ, Greenough A, Gamsu HR, Nicolaides KH Ventilatory requirements for respiratory distresss syndrome in small for gestational age infants. Eur J Pediatr 1992, 151:528.
151. Towers CV, Garite TJ Evaluation of the new Amnio Stat-FLM test for the detection of phosphatidylglycerol in contaminated fluids. Am J Obstet Gynecol 1989, 160:298.
152. Tubman TRJ, Rollins MD, Patterson C, Halliday HL Increased incidence of respiratory distress syndrome in babies of hypertensive mothers. Arch Dis Child 1991, 66:52.
153. Tyson JE, Kennedy K, Broyles S, Rosenfeld CA The small for gestational age infant: Accelerated or delayed pulmonary maturation?. Increased or decreased survival? Pediatrics 1995, 95:534.
154. Ueda T, Ikegami M, Jobe AH Developmental changes of sheep surfactant: In vivo function and in vitro subtype conversion. J Appl Physiol 1994, 76:2701.
155. Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res 1990, 53:157.
156. Usher R Reduction in mortality from respiratory distress syndrome and prematurity with early administration of intravenous glucose and sodium bicarbonate. Pediatrics 1963, 32:966.
157. Usher RH, Allen AC, McLean FH Risk of respiratory distress syndrome related to gestational age, route of delivery and maternal diabetes. Am J Obstet Gynecol 1971, 111:826.
158. Van Marter LJ, Allred EN, Pagano M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000, 105:1194.
159. Van Marter LJ, Leviton A, Kuban KCK, et al. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics 1990, 86:331.
160. Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994, 331:1051.
161. Versmold HT, Kitterman JA, Phibbs RH, et al. Aortic blood pressure during the first 12 hours of life in infants with birthweight 610-4220 grams. Pediatrics 1981, 67:607.
162. Walters DV, Olver RW The role of catecholamines in lung liquid absorption at birth. Pediatr Res 1978, 12:239.
163. Walther FJ, Siassi B, Ramadan NA, et al. Cardiac output in infants with transient myocardial dysfunction. J Pediatr 1985, 107:781.
164. West JB Ventilation perfusion inequality and overall gas exchange in computer models of the lung. Respir Physiol 1969, 7:88.
165. Wilkie RA, Bryan MH, Tarnow-Mordi WO Static respiratory compliance in the newborn. 2 Its potential for selection of infants for early surfactant treatment. Arch Dis Child 1994, 70:F16.
166. Wiswell TE, Rawlings JS, Smith FR, Goo ED Effect of furosemide on the clinical course of transient tachypnea of the newborn. Pediatrics 1985, 75:908.
167. Wright LL, Horbar JD, Gunkel H, et al. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants. Am J Obstet Gynecol 1995, 173:263.
168. Yoon JJ, Kohl S, Harper RG The relationship between maternal hypertensive disease of pregnancy and the incidence of idiopathic respiratory distress syndrome. Pediatrics 1980, 65:735.
169. Zuckerman B, Maynard EC, Cabral H A preliminary report of prenatal cocaine exposure and respiratory distress syndrome in premature infants. Am J Dis Child 1991, 145:696.